- Home
- ONEG vs ITRM Comparison
ONEG vs ITRM Comparison
Compare ONEG & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONEG
- ITRM
- Stock Information
- Founded
- ONEG 2021
- ITRM 2015
- Country
- ONEG Hong Kong
- ITRM Ireland
- Employees
- ONEG N/A
- ITRM N/A
- Industry
- ONEG Homebuilding
- ITRM Biotechnology: Pharmaceutical Preparations
- Sector
- ONEG Consumer Discretionary
- ITRM Health Care
- Exchange
- ONEG Nasdaq
- ITRM Nasdaq
- Market Cap
- ONEG 41.4M
- ITRM 49.5M
- IPO Year
- ONEG 2024
- ITRM 2018
- Fundamental
- Price
- ONEG $2.36
- ITRM $1.49
- Analyst Decision
- ONEG
- ITRM Strong Buy
- Analyst Count
- ONEG 0
- ITRM 1
- Target Price
- ONEG N/A
- ITRM $5.00
- AVG Volume (30 Days)
- ONEG 18.0K
- ITRM 635.0K
- Earning Date
- ONEG 01-01-0001
- ITRM 02-07-2025
- Dividend Yield
- ONEG N/A
- ITRM N/A
- EPS Growth
- ONEG N/A
- ITRM N/A
- EPS
- ONEG 0.16
- ITRM N/A
- Revenue
- ONEG $63,463,000.00
- ITRM N/A
- Revenue This Year
- ONEG N/A
- ITRM N/A
- Revenue Next Year
- ONEG N/A
- ITRM $160.88
- P/E Ratio
- ONEG $15.01
- ITRM N/A
- Revenue Growth
- ONEG 16.46
- ITRM N/A
- 52 Week Low
- ONEG $1.96
- ITRM $0.81
- 52 Week High
- ONEG $4.05
- ITRM $3.02
- Technical
- Relative Strength Index (RSI)
- ONEG N/A
- ITRM 46.16
- Support Level
- ONEG N/A
- ITRM $1.42
- Resistance Level
- ONEG N/A
- ITRM $1.58
- Average True Range (ATR)
- ONEG 0.00
- ITRM 0.11
- MACD
- ONEG 0.00
- ITRM 0.02
- Stochastic Oscillator
- ONEG 0.00
- ITRM 61.76
About ONEG OneConstruction Group Limited Ordinary Shares
OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. It is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction project include performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.